ASP Isotopes Subsidiary Secures $64.3 Million in Convertible Note Financing

Reuters
Nov 15, 2025
ASP Isotopes Subsidiary Secures $64.3 Million in Convertible Note Financing

ASP Isotopes Inc., through its wholly owned subsidiary Quantum Leap Energy LLC (QLE), has entered into a Convertible Note Purchase Agreement with institutional and individual investors to issue approximately $64.3 million in convertible promissory notes. The offering targets accredited and certain non-U.S. investors, with the initial closing expected around November 17 or 18, 2025, subject to customary conditions. Proceeds from the notes will be used to build and develop QLE's laser enrichment production facilities and for general corporate purposes. Upon closing, QLE's outstanding convertible notes from March and June 2024 will automatically convert into the new 2025 notes. The agreement does not include any financial covenants, and the notes have not been registered under the Securities Act.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ASP Isotopes Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-25-008327), on November 14, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10